Minorities face longer wait times for vital lung cancer treatment, study finds (IMAGE)
Caption
“Our results suggest that non-white lung cancer patients have delayed time to cancer treatment compared with white patients, and this is not limited to a particular type of treatment facility," said senior researcher Rajesh Balkrishnan, PhD, of UVA Cancer Center and the University of Virginia School of Medicine’s Department of Public Health Sciences.
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of the lung cancer findings. All other uses require express written permission from UVA Health.
License
Original content